NYSE:PG
NYSE:PGHousehold Products

Is Procter & Gamble (PG) Still A Long Term Hold After Recent Share Price Rebound

If you are wondering whether Procter & Gamble at around US$150 a share is still a solid long term holding or starting to look expensive, the key question is what you are really paying for today. The stock has returned 3.9% over the last 7 days and 3.7% over the last month, while the 1 year return sits at a 6.0% decline compared to gains of 15.3% over 3 years and 32.9% over 5 years. Recent headlines have continued to focus on Procter & Gamble as a global consumer staples heavyweight, with...
NYSE:DG
NYSE:DGConsumer Retailing

Dollar General Settlement Puts Pricing Integrity And Valuation In The Spotlight

Dollar General has agreed to a $15 million class action settlement addressing allegations of deceptive pricing practices. The case centers on claims that checkout prices did not match lower shelf prices advertised in stores. As part of the settlement, the company plans to provide monetary payouts and adopt corrective measures including third party pricing audits and stronger pricing oversight. For investors watching NYSE:DG, this legal development comes with the stock recently closing at...
NYSE:CHE
NYSE:CHEHealthcare

Should Jefferies’ Downgrade and Medicare Cap Limits Require Action From Chemed (CHE) Investors?

Earlier this week, Jefferies downgraded Chemed Corporation after highlighting profitability pressures in its Roto-Rooter segment and weaker-than-expected residential plumbing demand in the second quarter. The company also flagged a significant anticipated Medicare Cap revenue limitation for its VITAS hospice subsidiary in Florida for fiscal 2025, raising fresh questions about its healthcare earnings mix. Next, we’ll examine how concerns around Roto-Rooter profitability shape Chemed’s...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

FormFactor (FORM) Valuation Check After Hedgeye Short Call And Intel Guidance Cut

Why FormFactor Is Back in Focus for Investors FormFactor (FORM) is in the spotlight after a new Hedgeye short thesis flagged valuation concerns tied to Intel’s guidance cut, while other market commentary highlights rising semiconductor test demand and recent earnings estimate revisions. See our latest analysis for FormFactor. FormFactor’s latest share price of US$73.20 comes after a sharp 9.63% 1-day share price decline and a 6.53% 7-day pullback, which contrast with a 26.08% 1-month and...
NYSE:NPKI
NYSE:NPKITrade Distributors

Does Riverwater’s New Stake in NPKI Change The Bull Case For Its Composite Mat Advantage?

During Q4 2025, Riverwater Partners’ Small Cap Strategy initiated a new position in NPK International Inc., citing its role in supplying composite mat solutions for the multi‑year infrastructure buildout underpinning grid expansion and energy system upgrades. The investor highlighted that NPK International’s composite mats, with longer useful life, easier transport and superior cost efficiency versus timber alternatives, place the company at a potential inflection point as it pursues...
NYSE:TRV
NYSE:TRVInsurance

A Look At Travelers Companies (TRV) Valuation After Strong Earnings And Expanded Buyback Program

Travelers Companies (TRV) is back in focus after reporting fourth quarter earnings that came in well above expectations, while also lifting its share buyback authorization and reaffirming its regular quarterly dividend. See our latest analysis for Travelers Companies. The share price has had a mixed few months, with a 7 day share price return of 3.1%, a 30 day share price return of 4.9%, and a year to date share price return of a 2.6% decline. At the same time, the 1 year total shareholder...
NasdaqGS:NVAX
NasdaqGS:NVAXBiotechs

Novavax (NVAX) Is Up 14.5% After Licensing Matrix-M Adjuvant Platform To Pfizer – Has The Bull Case Changed?

In January 2026, Novavax announced a non-exclusive worldwide License and Option Agreement granting Pfizer access to its Matrix-M adjuvant technology for vaccine development in up to two infectious disease areas, in return for a US$30,000,000 upfront payment and the potential for additional milestones and royalties. The deal effectively shifts development and commercialization responsibilities to Pfizer while positioning Novavax as a specialist supplier of its proprietary adjuvant,...
NasdaqGS:TBBK
NasdaqGS:TBBKBanks

A Look At The Bancorp (TBBK) Valuation As Earnings Expectations Turn More Cautious

Heightened attention around Bancorp (TBBK) has built ahead of its upcoming quarterly earnings, with a negative Earnings ESP of 0.69% and growing focus on whether the bank will meet or miss expectations. See our latest analysis for Bancorp. The recent share price moves reflect this tension, with a 1 day share price return of a 5.75% decline and a 90 day share price return of a 14.73% decline, contrasting with a 1 year total shareholder return of 20.93%. This suggests longer term momentum,...
NYSE:VG
NYSE:VGOil and Gas

Venture Global (VG) Valuation Check After Arbitration Win Against Repsol

Venture Global (VG) is back in focus after winning an International Chamber of Commerce arbitration against Repsol, a ruling that validated its LNG terminal operations and ordered reimbursement of legal expenses. See our latest analysis for Venture Global. The arbitration win has arrived alongside a sharp swing in market sentiment, with a 1 month share price return of 42.16% and a year to date share price return of 40.34%. However, the 1 year total shareholder return is still down 58.55%,...
NYSE:AGO
NYSE:AGOInsurance

Did Assured’s Move Into Annuity Reinsurance Just Shift Assured Guaranty's (AGO) Investment Narrative?

Earlier in 2026, Assured Guaranty Ltd. acquired Bermuda-based life and annuity reinsurer Warwick Re Limited, renaming it Assured Life Reinsurance Ltd. and positioning the business to reinsure fixed-term and pension risk transfer annuities. This move gives Assured Guaranty an immediate operating platform in the annuity reinsurance space, adding a new line of risk exposure and revenue diversification beyond its traditional financial guaranty operations. We’ll now examine how Assured Guaranty’s...
NYSE:WHD
NYSE:WHDEnergy Services

Assessing Cactus (WHD) Valuation After A Strong Short Term Share Price Run

Why Cactus Stock Is On Investors’ Radar Today Cactus (WHD) has recently caught investor attention after a period of mixed share performance, with a monthly gain alongside a negative 1-year total return. This divergence has prompted closer scrutiny of its current valuation. See our latest analysis for Cactus. At a share price of US$53.47, Cactus has seen strong near term momentum, with a 30 day share price return of 16.21% and a 90 day gain of 34.18%. This comes as the 1 year total shareholder...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Rocket Lab Neutron Tank Rupture Tests Medium Lift Growth Timeline

Rocket Lab (NasdaqCM:RKLB) reported a rupture of the Neutron Stage 1 tank during a hydrostatic pressure test. The incident occurred during qualification testing of the medium lift rocket's first stage. The company described the event as part of normal validation, stating that no significant damage was recorded. The rupture introduces uncertainty around Neutron's development timeline and potential effects on upcoming launches. Neutron is central to Rocket Lab's push beyond small payloads...
NasdaqCM:FCAP
NasdaqCM:FCAPBanks

First Capital (FCAP) Earnings Growth And 33.1% Margins Reinforce Bullish Community Narrative

First Capital (FCAP) closed out FY 2025 with fourth quarter revenue of US$13.1 million and basic EPS of US$1.46, while trailing twelve month totals reached US$49.5 million of revenue and EPS of US$4.89. Over the past few quarters, revenue has ranged from US$10.5 million in Q3 2024 to US$13.1 million in Q4 2025, with quarterly EPS moving from US$0.87 in Q3 2024 to US$1.46 most recently, alongside trailing net income of US$16.4 million. With a net profit margin of 33.1% over the last year...